Pharmena S.A.
ISIN: PLPHRMN00011 | Ticker: PHR | LEI: 259400RHT936BBKW0955
Country: Poland
Pharmena S.A. is a Polish publicly traded specialty healthcare company that develops and markets innovative products based on natural and patented solutions . Its product portfolio includes cosmeceuticals and pharmaceuticals, and its activity focuses on three main areas such as research in the United States and Canada, sourcing of raw materials, and the production of final products in Poland. Pharmena is dedicated to supplying innovative solutions for healthcare, based on natural ingredients, and patent protection. The company has also developed dietary supplements, including the group of specialized dietary supplements called Menavitin .
Year founded2002
Served areaWorldwide
HeadquartersWólczańska 178, 90-530 Łódź – Poland
| Line item in (pln) | 02.01.2020 | 01.01.2021 | 02.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|
| Assets | N/A | 10,950,000.00 | N/A | 11,151,000.00 | 12,579,000.00 |
| Noncurrent Assets | N/A | 2,686,000.00 | N/A | 2,953,000.00 | 2,609,000.00 |
| Property Plant And Equipment | N/A | 50,000.00 | N/A | 40,000.00 | 48,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 1,007,000.00 | N/A | 966,000.00 | 999,000.00 |
| Noncurrent Receivables | N/A | 250,000.00 | N/A | 201,000.00 | 165,000.00 |
| Deferred Tax Assets | N/A | 994,000.00 | N/A | 978,000.00 | 947,000.00 |
| Current Assets | N/A | 8,264,000.00 | N/A | 8,198,000.00 | 9,970,000.00 |
| Inventories | N/A | 3,997,000.00 | N/A | 3,462,000.00 | 4,563,000.00 |
| Trade And Other Current Receivables | N/A | 2,545,000.00 | N/A | 3,276,000.00 | 3,815,000.00 |
| Cash and cash equivalents | 1,048,000.00 | 1,722,000.00 | 1,722,000.00 | 1,460,000.00 | 1,592,000.00 |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 8,264,000.00 | N/A | 8,198,000.00 | 9,970,000.00 |
| Equity And Liabilities | N/A | 10,950,000.00 | N/A | 11,151,000.00 | 12,579,000.00 |
| Equity | 4,996,000.00 | -348,000.00 | -348,000.00 | -5,121,000.00 | -6,792,000.00 |
| Issued Capital | N/A | 1,098,000.00 | N/A | 1,113,000.00 | 1,113,000.00 |
| Retained Earnings | N/A | -45,750,000.00 | N/A | -50,357,000.00 | -51,927,000.00 |
| Share Premium | N/A | 44,177,000.00 | N/A | 44,177,000.00 | 44,177,000.00 |
| Equity Attributable To Owners Of Parent | N/A | -139,000.00 | N/A | -4,865,000.00 | -6,490,000.00 |
| Noncontrolling Interests | N/A | -209,000.00 | N/A | -256,000.00 | -302,000.00 |
| Liabilities | N/A | 11,298,000.00 | N/A | 16,272,000.00 | 19,371,000.00 |
| Noncurrent Liabilities | N/A | 163,000.00 | N/A | 4,694,000.00 | 2,401,000.00 |
| Noncurrent Provisions | N/A | 26,000.00 | N/A | 24,000.00 | 61,000.00 |
| Noncurrent Provisions For Employee Benefits | N/A | 26,000.00 | N/A | 24,000.00 | 16,000.00 |
| Other Longterm Provisions | N/A | N/A | N/A | 0.00 | 45,000.00 |
| Other Noncurrent Financial Liabilities | N/A | 0.00 | N/A | 4,180,000.00 | 2,146,000.00 |
| Current Liabilities | N/A | 11,135,000.00 | N/A | 11,578,000.00 | 16,970,000.00 |
| Current Provisions | N/A | N/A | N/A | 0.00 | 5,000.00 |
| Current Provisions For Employee Benefits | N/A | N/A | N/A | 0.00 | 5,000.00 |
| Trade And Other Current Payables | N/A | 5,722,000.00 | N/A | 6,372,000.00 | 8,988,000.00 |
| Current Tax Liabilities Current | N/A | 40,000.00 | N/A | 167,000.00 | 174,000.00 |
| Other Current Financial Liabilities | N/A | 5,121,000.00 | N/A | 4,747,000.00 | 7,487,000.00 |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 11,135,000.00 | N/A | 11,578,000.00 | 16,970,000.00 |
| Line item in (pln) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 9,933,000.00 | 15,213,000.00 | 19,022,000.00 |
| Other Income | 263,000.00 | 71,000.00 | 13,000.00 |
| Profit Loss From Operating Activities | -6,008,000.00 | -3,983,000.00 | -508,000.00 |
| Finance Income | 0.00 | 0.00 | 0.00 |
| Finance Costs | 264,000.00 | 474,000.00 | 904,000.00 |
| Profit Loss Before Tax | -6,272,000.00 | -4,457,000.00 | -1,412,000.00 |
| Income Tax Expense Continuing Operations | 686,000.00 | 182,000.00 | 204,000.00 |
| Profit Loss From Continuing Operations | -6,958,000.00 | -4,639,000.00 | -1,616,000.00 |
| Profit Loss From Discontinued Operations | 0.00 | 0.00 | 0.00 |
| Profit (loss) | -6,958,000.00 | -4,639,000.00 | -1,616,000.00 |
| Profit Loss Attributable To Owners Of Parent | -6,891,000.00 | -4,592,000.00 | -1,570,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | -67,000.00 | -47,000.00 | -46,000.00 |
| Line item in (pln) | 01.01.2021 | 02.01.2020 | 01.01.2022 | 02.01.2021 | 01.01.2023 |
|---|---|---|---|---|---|
| Profit (loss) | -6,958,000.00 | N/A | -4,639,000.00 | N/A | -1,616,000.00 |
| Adjustments For Reconcile Profit Loss | 3,877,000.00 | N/A | 1,271,000.00 | N/A | 3,398,000.00 |
| Adjustments For Decrease Increase In Inventories | -148,000.00 | N/A | 535,000.00 | N/A | -1,101,000.00 |
| Adjustments For Increase Decrease In Trade Account Payable | 2,486,000.00 | N/A | 612,000.00 | N/A | N/A |
| Adjustments For Depreciation And Amortisation Expense | 628,000.00 | N/A | 626,000.00 | N/A | 561,000.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | 126,000.00 | N/A | -132,000.00 | N/A | -56,000.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | -16,000.00 | N/A | 53,000.00 | N/A | 162,000.00 |
| Other Adjustments To Reconcile Profit Loss | -4,000.00 | N/A | 6,000.00 | N/A | 7,000.00 |
| Adjustments For Reconcile Profit Loss | 3,877,000.00 | N/A | 1,271,000.00 | N/A | 3,398,000.00 |
| Cash Flows From Used In Operations | -2,395,000.00 | N/A | -3,186,000.00 | N/A | 1,986,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | -158,000.00 | N/A | 39,000.00 | N/A | 167,000.00 |
| Cash Flows From Used In Operating Activities | -2,237,000.00 | N/A | -3,225,000.00 | N/A | 1,819,000.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | N/A | 0.00 | N/A | 4,000.00 |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | 16,000.00 | N/A | 71,000.00 | N/A | N/A |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | 214,000.00 | N/A | 319,000.00 | N/A | N/A |
| Cash Flows From Used In Investing Activities | -198,000.00 | N/A | -248,000.00 | N/A | -219,000.00 |
| Proceeds From Issuing Shares | 1,508,000.00 | N/A | 0.00 | N/A | N/A |
| Proceeds From Borrowings Classified As Financing Activities | 1,002,000.00 | N/A | 4,550,000.00 | N/A | 0.00 |
| Repayments Of Borrowings Classified As Financing Activities | 0.00 | N/A | 10,000.00 | N/A | 370,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | 320,000.00 | N/A | 255,000.00 | N/A | 284,000.00 |
| Interest Paid Classified As Financing Activities | 123,000.00 | N/A | 248,000.00 | N/A | 624,000.00 |
| Other Inflows Outflows Of Cash Classified As Financing Activities | 1,048,000.00 | N/A | -823,000.00 | N/A | -188,000.00 |
| Cash Flows From Used In Financing Activities | 3,115,000.00 | N/A | 3,214,000.00 | N/A | -1,466,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 680,000.00 | N/A | -259,000.00 | N/A | 134,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -6,000.00 | N/A | -3,000.00 | N/A | -2,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 674,000.00 | N/A | -262,000.00 | N/A | 132,000.00 |
| Cash and cash equivalents | 1,722,000.00 | 1,048,000.00 | 1,460,000.00 | 1,722,000.00 | 1,592,000.00 |
Please note that some sums might not add up.
PLPHRMN00011
LEI259400RHT936BBKW0955
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.